The federal hearing on moving marijuana to Schedule III picked up another wrinkle this week.
Last month, DEA Chief Administrative Law Judge Derek Julius paused the proceedings after rescheduling opponents asked to add a recent Government Accountability Office (GAO) report to the record. That report found "gaps" in how DEA and the FDA document their drug-scheduling process. In a brief filed Friday and obtained by Marijuana Moment on Tuesday, DEA said it defers to the judge on whether the report gets added, but opposes extra briefings about it, arguing the report "does not present any new evidence salient to the issue."
Opponents want more. Smart Approaches to Marijuana and the states of Idaho, Indiana and Nebraska asked for supplemental briefing. Another group of opponents filed a motion asking the judge to reopen the hearing for limited document discovery and testimony.
Before the pause, the only step left was Julius' recommendation to the DEA administrator, who makes the final call. Separately, state-licensed medical cannabis already moved to Schedule III under an April order, and the broader rescheduling also faces lawsuits in a federal appeals court.
What it means for travelers: this is a slow federal process, and nothing about state rules changes for now. In legal states, keep following local purchase and possession limits, and remember cannabis still can't cross state lines.






